Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Evaluate the Safety, Tolerability, and Preliminary Efficacy of EVM14 Alone and in Combination in Patients With Selected Solid Tumors

Brief Summary: The purpose of this clinical trial is to evaluate the safety, tolerability, preliminary efficacy, and immunogenicity of EVM14 administered intramuscularly (IM) alone and in combination with pembrolizumab in patients with selected solid tumors.

Participants needed: 94
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Everest Medicines (Beijing) Co., Ltd.Updated: Aug 4, 2026Locations: 7
Eligibility criteria

Selected types of solid tumor that are pathologically confirmed unresectable adv... [+5]

Has disease that is suitable for local treatment administered with curative inte... [+12]

Status: Not yet recruiting

Evaluate the Safety, Tolerability, and Preliminary Efficacy of EVM14 in Combination With Ivonescimab in Sq-NSCLC Patients

The purpose of this clinical trial is to evaluate the safety, tolerability, preliminary efficacy, and immunogenicity of EVM14 administered intramuscularly (IM) combination with Ivonescimab in patients with sq-NSCLC.

Participants needed: 13
Trial details
Phase: Phase 1Age: 18-99Biological sex: AllType: InterventionalSponsor: Everest Medicines (Beijing) Co., Ltd.Updated: May 29, 2026
Eligibility criteria

Pathologically confirmed locally advanced (Stage IIIB/IIIC) or metastatic (Stage... [+6]

Has disease that is suitable for local treatment administered with curative inte... [+7]